Alzheimer's, ADHD, Autism, Brain Injury Treatment, Mood Disorders New Jersey: The NeuroCognitive and Behavioral Institute » New Approaches to Diagnosing and Treating Cognitive and Neurobehavioral Problems in Patients with Traumatic Brain Injury

Free Zoom Webinar with Dr. Gerald Tramontano, in partnership with The Brain Injury Alliance of New Jersey (BIANJ)

New Approaches to Diagnosing and Treating Cognitive and Neurobehavioral Problems in Patients with TBI

Thursday, October 15, 2020 at 3:00PM Eastern Time (US and Canada)

By the end of this 60-minute webinar you will understand:
– Current neurodiagnostic and treatment approaches in TBI
– The need for better diagnostics
– New approaches to treating neurobehavioral problems
– The rationale for these new approaches and how they may help patients and families

Dr. Tramontano specializes in the practice of clinical neuropsychology. As the Medical Director for The NeuroCognitive and Behavioral Institute (NCBI), he provides direct patient care and supervises clinicians, medical and psychological interns, residents and fellows in clinical neuropsychology, behavioral neurology and neurology. NCI serves patients with a variety of cognitive and neuropsychiatric conditions ranging from ADHD, through Alzheimer’s disease; including traumatic and acquired brain injury.

Missed the live webinar?

Watch the recording at your convenience. Feel free to reach out to us if you have any questions.

Presenter: Gerald Tramontano, Ph.D., Medical Director

About Dr. Tramontano:
Dr. Gerald Tramontano conducts a variety of sponsored and investigator-initiated pharmacological, nutraceutical and neurodiagnostic research. As a Principal Investigator, Dr. Tramontano has completed approximately 70 clinical research studies. His clinical research experience in drug development ranges from bioavailabilty / bioequivalent studies, as well as, first in humans Phase I studies through Phase IV clinical trials. The majority of his clinical research has been investigating functional brain mapping, neuromodulation, behavioral, biological and pharmacological treatments for patients with a variety of cognitive and neuropsychiatric conditions, in particular – neurodegenerative diseases such as Alzheimer’s disease. He has authored several published neuroscience-related and pharmacology articles in medical and forensic journals. Read more about Dr. Tramontano.


Call Now Button